Caroline J. Loew, Ph.D

President & Chief Executive Officer

Dr. Loew is a biotech CEO with almost 30 years of drug development and commercialization experience. She most recently served as president and CEO of Mural Oncology, a publicly traded immuno-oncology company, and previously was president and CEO at Glympse Bio, a biotechnology company based in Cambridge, Mass. Prior to Glympse, Caroline was vice president and head of R&D Strategy and Planning at Bristol-Myers Squibb (BMS). At BMS, she led portfolio strategy and operations in a broad role that included delivering strong competitive positioning for the Immuno-Oncology, Immunoscience, Fibrosis and Cardiovascular portfolios, as well as a fit-for-purpose operating model. Caroline joined BMS following leadership roles at Merck and PhRMA, where she led market access, commercial portfolio management, and regulatory policy. Caroline holds a PhD in Organic Chemistry and BSc in Chemistry from Imperial College London.